Rehmapicrogenin is primarily studied for its potential anti-inflammatory and neuroprotective effects. It has shown activity in modulating pathways related to oxidative stress, making it a compound of interest in research on neurodegenerative conditions such as Alzheimer's and Parkinson’s disease. Preliminary studies suggest it may help in reducing neuronal damage by inhibiting pro-inflammatory cytokines and enhancing antioxidant defenses. Additionally, it has been investigated for its hepatoprotective properties, offering potential in protecting liver cells from toxin-induced damage. Due to its bioactive profile, Rehmapicrogenin serves as a lead compound in the development of natural product-based therapeutics, especially in traditional medicine-inspired drug discovery.